|
|
|
40
|
6451AA
|
MAXITROL 1MG/ML | 3MG/ML | 10,000U EYE DR (NVS/COL) DEXAMETHASONE | NEOMYCIN | P More ...
|
DEXAMETHASONE|NEOMYCIN|POLYMYXIN B
|
MAXITROL
|
5ML
|
BQ
|
32.08
|
32.08
|
EYE DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
6451AE
|
4-QUIN D 0.1%|0.5% EYE DR (HAN) DEXAMETHASONE|MOXIFLOXACIN (BQ)
|
DEXAMETHASONE|MOXIFLOXACIN
|
4-QUIN D
|
5ML
|
BQ
|
3.94
|
3.9416
|
BOTT
|
1
|
BOTT
|
HAN
|
HANUCHEM LABORATORIES
|
PSB
|
PHARMACEUTICAL SOLUTIONS BARBA
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6451L
|
QUIDEX EYE DROP (LPO/COL) CIPRO/DEXAM
|
CIPROFLOXACIN|DEXAMETHASONE
|
QUIDEX
|
5ML
|
B
|
8.15
|
8.15
|
EYE DROP
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
6451L
|
QUIDEX 0.3%|0.1% EYE DR (LPO) CIPROFLOXACIN|DEXAMETHASONE (BH)
|
CIPROFLOXACIN|DEXAMETHASONE
|
QUIDEX
|
5ML
|
BH
|
8.97
|
8.9705
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6451L
|
QUIDEX 0.3%|0.1% EYE DR (LPO) CIPROFLOXACIN|DEXAMETHASONE
|
CIPROFLOXACIN|DEXAMETHASONE
|
QUIDEX
|
5ML
|
B
|
16.31
|
16.31
|
BOTT
|
1
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
40
|
6451M
|
MAXISPORIN 1MG/ML | 3MG EYE DR (ASL/PHA) DEXAMETHASONE | NEOMYCIN | POLYMYXIN B
|
DEXAMETHASONE|NEOMYCIN|POLYMYXIN B
|
MAXISPORIN
|
5ML
|
BQ
|
5.52
|
5.52
|
EYE DROP
|
0
|
BOTT
|
ASL
|
ASHFORD LABORATORIES LTD
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
6451R
|
GATIDEX 0.1% | 0.3% EYE DR (LPO/COL) DEXAMETHASONE | GATIFLOXACIN
|
DEXAMETHASONE|GATIFLOXACIN
|
GATIDEX
|
5ML
|
BQ
|
9.51
|
9.51
|
EYE DROP
|
0
|
BOTT
|
LPO
|
LABORATORIOS POEN S.A.
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
6451Y
|
CIPRODEX 0.3% | 0.1% EAR DR (NVS/COL) CIPROFLOX
|
CIPROFLOXACIN|DEXAMETHASONE
|
CIPRODEX
|
7.5ML
|
C
|
29.68
|
29.68
|
EAR DROP
|
0
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
0
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
40
|
6451Z
|
VIGADEXA 0.1% | 0.5% EYE DR (NVS/COL) DEXAMETHA
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
BQ
|
20.39
|
20.39
|
EYE DROP
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2022-04-01
|
2024-03-31
|
|
OPHTHALMIC
|
6
|
EYE, EAR, NOSE AND THROAT PREPARATIONS
|
|
|
|
|
41
|
6451Z
|
VIGADEXA 0.1%|0.5% EYE DR (NVS) DEXAMETHASONE|MOXIFLOXACIN (C)
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
C
|
20.39
|
20.3874
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
COLLINS LTD
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2024-04-01
|
2026-03-31
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
42
|
6451Z
|
VIGADEXA 0.1%|0.5% EYE DR (NVS) DEXAMETHASONE|MOXIFLOXACIN
|
DEXAMETHASONE|MOXIFLOXACIN
|
VIGADEXA
|
5ML
|
C
|
20.39
|
20.39
|
BOTT
|
1
|
BOTT
|
NVS
|
NOVARTIS CARIBE SA
|
COL
|
AVENTA BARBADOS
|
|
5206
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
2026-04-01
|
|
|
OPHTHALMIC
|
6
|
ANTIBACTERIAL-ANTI-INFLAMMATORY AGENTS
|
|
|
|
|
41
|
64611
|
SULPHADIAZINE 500MG TAB (JOL) SILVER SULPHADIAZINE (C)
|
SULPHASALAZINE
|
SULPHADIAZINE
|
100'S
|
C
|
76.47
|
0.7647
|
TAB
|
0
|
BOX
|
JOL
|
JOLLY PHARMACEUTICALS
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
081220
|
SULPHONAMIDES
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
SULPHONAMIDES
|
|
|
|
|
42
|
64916
|
CALCIUM CHLORIDE 10% INJ (MTP)
|
CALCIUM CHLORIDE
|
CALCIUM CHLORIDE
|
10ML AMP
|
B
|
40.99
|
40.99
|
AMPG
|
0
|
AMP
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
4012
|
REPLACEMENT THERAPY
|
2026-04-01
|
|
|
IV
|
0
|
REPLACEMENT THERAPY
|
|
|
|
|
40
|
65216
|
PENTAMIDINE 300MG INJ (DIL/AHI)
|
PENTAMIDINE
|
PENTAMIDINE
|
10X15ML
|
C
|
6,415.24
|
641.52
|
INJECTION
|
0
|
VIAL
|
DIL
|
FRESENIUS KABI
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
083092
|
ANTIPROTOZOALS, MISCELLANEOUS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
6561D
|
MESAGUT 400MG TAB (ARP/AHI) MESALAZINE
|
MESALAZINE
|
MESAGUT
|
30'S
|
BQ
|
16.91
|
0.56
|
TABLET
|
0
|
TAB
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5632
|
GI PROKINETIC AGENTS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
GASTROINTESTINAL DRUGS
|
|
|
|
|
42
|
6561D
|
MESAGUT 400MG TAB (ARP) MESALAZINE
|
MESALAZINE
|
MESAGUT
|
30'S
|
BQ
|
12.97
|
0.43
|
TAB
|
0
|
BLIS
|
ARP
|
ARISTOPHARMA LTD
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
5632
|
GI PROKINETIC AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
GI PROKINETIC AGENTS
|
|
|
|
|
40
|
6561G
|
PENTASA 500MG TAB (FER/STO) MESALAZINE
|
MESALAZINE
|
PENTASA
|
50'S
|
BQ
|
89.22
|
1.78
|
TABLET
|
0
|
TAB
|
FER
|
FERRING PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2022-04-01
|
2024-03-31
|
Package Size Change
|
oral
|
6
|
GASTROINTESTINAL DRUGS
|
2022-03-18
|
|
|
|
41
|
6561G
|
PENTASA 500MG TAB (FER) MESALAZINE
|
MESALAZINE
|
PENTASA
|
50'S
|
BQ
|
95.49
|
1.9099
|
TAB
|
0
|
BOX
|
FER
|
FERRING PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
0
|
GI PROKINETIC AGENTS
|
|
|
|
|
42
|
6561G
|
PENTASA 500MG TAB (FER) MESALAZINE
|
MESALAZINE
|
PENTASA
|
50'S
|
BQ
|
107.10
|
2.14
|
TAB
|
0
|
BLIS
|
FER
|
FERRING PHARMACEUTICALS LTD
|
STO
|
BRYDEN STOKES LTD
|
|
5632
|
GI PROKINETIC AGENTS
|
2026-04-01
|
|
|
ORAL
|
0
|
GI PROKINETIC AGENTS
|
|
|
|
|
40
|
65712
|
CLOZAPINE 25MG TAB (APL/AHI)
|
CLOZAPINE
|
CLOZAPINE
|
100'S
|
BP
|
97.32
|
0.97
|
TABLET
|
270
|
TAB
|
APL
|
AUROBINDO PHARMA LTD.
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
28160804
|
ATYPICAL ANTIPSYCHOTICS
|
2022-04-01
|
2022-07-30
|
|
Oral
|
6
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-29
|